|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/517 | (2006.01) |
| C12Q 1/68 | (2006.01) | ||
| G01N 33/569 | (2006.01) | ||
| G01N 33/574 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) |
| (11) | Number of the document | 2467140 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10810654.3 |
| Date of filing the European patent application | 2010-08-20 | |
| (97) | Date of publication of the European application | 2012-06-27 |
| (45) | Date of publication and mention of the grant of the patent | 2016-06-01 |
| (46) | Date of publication of the claims translation | 2016-09-12 |
| (86) | Number | PCT/US2010/046142 |
| Date | 2010-08-20 |
| (87) | Number | WO 2011/022633 |
| Date | 2011-02-24 |
| (30) | Number | Date | Country code |
| 307569 P | 2010-02-24 | US | |
| 235947 P | 2009-08-21 | US |
| (72) |
BING, Nan, US
BRILEY, Linda, Perry, US
BUDDE, Laura, R., US
COX, Charles, J., GB
SPRAGGS, Colin, F., GB
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Lapatinibas, skirtas vėžio gydymui |
| LAPATINIB FOR TREATING CANCER |
| Payment date | Validity (years) | Amount | |
| 2019-07-30 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2025-02-10 |